Ovarian Cancer Immunotherapy

Samir A. Farghaly, MD, PhD is a Professor Obstetrics and Gynecology at the Joan and Sanford I. Weill Medical College, Graduate School of Medical Sciences; Sandra and Edward Meyer Cancer Center; and New York-Presbyterian Hospital/Weill Cornell Medical Center in New York, NY. He received his MD and PhD in molecular biology from London University. Dr. Farghaly is the Founder and Editor-in Chief of Current Trends in Gynecologic Oncology, and The International Journal of Gynecological, Obstetrical, and Reproductive Medicine Research. He is a member of the editorial boards of 18 international medical journals on Gynecological Cancers, Gene Expression and Therapy, Women's Health, and Gynecology.

Chapter 1: Antibody Therapeutics for Ovarian Carcinoma and Translation to the Clinic
Debra H. Josephs, Heather J. Bax, Giulia Pellizzari, James F. Spicer, Ana Montes, and Sophia N. Karagiannis
Chapter 2: Biological Aspects and Clinical Applications of Serum Biomarkers in Ovarian Cancer
Rouba Ali- Fehmi and Eman Abdulfatah
Chapter 3: Ovarian Cancer Immunity: How Does Immune Suppression Grow Cancer?
Vincent Lavoué, Patrick Legembre, Jean Levêque, Fabrice Foucher, Sébastien Henno, and Florian Cabillic
Chapter 4: Ovarian Tumor Microenvironment and Innate Immune Recognition
Jocelyn Reader, Sarah Lynam, Amy Harper, Gautam Rao, Maya Matheny, and Dana M. Roque
Chapter 5: Adoptive Cell Immunotherapy for Epithelial Ovarian Cancer
Samir A. Farghaly
Chapter 6: Antibody-based Therapy for Ovarian Cancer
Yousef Alharbi, Manish S. Patankar, and Rebecca J. Whelan
Chapter 7: Epitope/Peptide-based Monoclonal Antibodies for Immunotherapy of Ovarian Cancer
Gregory Lee
Chapter 8: Dendritic Cell Vaccine Therapy for Ovarian Cancer
Caitlin Stashwick, Brian J. Czerniecki, Janos L. Tanyi
Chapter 9: Heat Shock Protein Vaccine Therapy for Ovarian Cancer
Hiroyuki Abe, Amane Sasada, Shigeki Tabata, and Minako Abe
Chapter 10: PD-1 /PDL-1 Inhibitors as Immunotherapy for Ovarian Cancer
Scott Moerdler and Xingxing Zang
Chapter 11: Growth Factors and Their Corresponding Receptors as Targets for Ovarian Cancer Therapy
Anca Maria Cimpean, Andreea Adriana Jitariu, and Marius Raica
Chapter 12: Unique Challenges Facing Immunotherapy of Metastatic Ovarian Cancer
Michelle N. Messmer, Colleen S. Netherby, and Scott I. Abrams
Chapter 13: Clinical Trials of Ovarian Cancer Immunotherapy and Future Directions
Justin M. Drerup, Curtis A. Clark, and Tyler J. Curiel